Bill Ackman's Pershing Square Takes 5% Stake In Valeant Pharmaceuticals
March 09, 2015 at 15:02 PM EDT
Bill Ackman, founder and CEO of hedge fund Pershing Square Capital Management, acquired a $3.3 billion stake in Valeant ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.